Gattefossé Continues International Development & Builds Production Site in Texas

Gattefossé is investing 30 million euros in its industrial operations and announced the construction of a brand new manufacturing plant in Lufkin, TX. This asset will produce lipid-based specialty ingredients for the personal care and pharmaceutical industries.

New Strategic Step for the Group

This new production site will enable the Group to respond to several strategic challenges:

• Deepen its presence in North America to better meet local customers’ needs
• Increase its global production capacity
• Provide back-up solutions on 3 continents and bring more supply flexibility to all customers.

Construction will begin in 2021 and the plant should deliver its first customers in 2024.

“North America is a leading region for the global pharmaceutical and personal care industries in terms of innovation, production and consumption, and has therefore a major impact on worldwide trends. The opening of a manufacturing unit represents an essential milestone in our strategy to enhance our local presence and commitment to this important and influential market. The label Made in USA will satisfy a strong demand expressed by our customers and the geographical location of this new site will facilitate logistics and supply chain. Production in Texas is first intended to serve the North American market but will gradually be extended to other regions,” said Eric Brun, President and CEO of Gattefossé USA and Canada.

Today, the Gattefossé Group operates 2 production sites, in Europe (France) and Asia (Singapore). The opening of a third manufacturing plant in the United States will improve the Group’s ability to better serve the American market and represents an extra step in the deployment of its industrial operations.

The company chose to set up a plant in Lufkin, Texas, because of its central position in North America, close to the important industrial pole in Houston. Lufkin is a dynamic up and coming city of 35,000 inhabitants located in the heart of a free trade zone.

“The international expansion of industrial operations is an essential step in the development of our Group. This project meets the economic and environmental challenges set by the company as part of its global strategy: innovation, customer intimacy, geographic expansion and social responsibility. Controlling our environmental impact is a priority: Gattefossé headquarters will be ISO 14001 certified in 2021 and the new American site will also meet this requirement, ” added Eduardo De Purgly, Gattefossé Group CEO.

Gattefossé is a French company that develops, manufactures, and sells specialty ingredients for the personal care and pharmaceutical industries. Specialist in lipid chemistry and plant extraction, the group offers recognized expertise in formulation using its 4 application laboratories.

Gattefossé markets its products in more than 60 countries through 12 affiliate companies and a network of agents and distributors. The company remains a family-run, independent business since its creation in 1880.

Since their creation in 1982 and 1997, Gattefossé USA and Gattefossé Canada enjoyed constant growth, expanding their presence. In 2017 a state-of-the-art application laboratories were inaugurated in Paramus, NJ.

Under the leadership of Eric Brun, PhD, the sales, marketing, technical support, logistics, and quality teams in the USA out of Paramus, (NJ), and in Canada out of Toronto (Ontario) and Montreal (Quebec) offices are fully committed to providing assistance and expertise to pharmaceutical and cosmetic customers in North-America.